Sinclair Pharma PLC (SPH) Receives Buy Rating from Peel Hunt

Peel Hunt reissued their buy rating on shares of Sinclair Pharma PLC (LON:SPH) in a research report report published on Monday morning. The firm currently has a GBX 68 ($0.87) price objective on the specialty pharmaceutical company’s stock.

Several other research analysts also recently weighed in on SPH. Stifel Nicolaus reissued a buy rating and issued a GBX 71 ($0.90) target price on shares of Sinclair Pharma PLC in a research note on Tuesday, March 21st. N+1 Singer reissued a buy rating and issued a GBX 42 ($0.54) target price on shares of Sinclair Pharma PLC in a research note on Tuesday, March 21st. Jefferies Group LLC reissued a buy rating and issued a GBX 55 ($0.70) target price on shares of Sinclair Pharma PLC in a research note on Wednesday, March 22nd. Finally, Numis Securities Ltd reissued a hold rating and issued a GBX 35 ($0.45) target price on shares of Sinclair Pharma PLC in a research note on Tuesday, April 4th. One analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of Buy and an average price target of GBX 54 ($0.69).

Shares of Sinclair Pharma PLC (LON SPH) traded up 2.48% during midday trading on Monday, hitting GBX 31.00. 5,559 shares of the stock were exchanged. The firm has a 50-day moving average price of GBX 32.49 and a 200 day moving average price of GBX 32.38. Sinclair Pharma PLC has a 12-month low of GBX 26.00 and a 12-month high of GBX 36.35. The firm’s market cap is GBX 155.68 million.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Mideast Time and is the sole property of of Mideast Time. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.mideasttime.com/sinclair-pharma-plc-sph-receives-buy-rating-from-peel-hunt/1795562.html.

About Sinclair Pharma PLC

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “LSE:SPH”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.